Insider · CIK 0001744887
Hanson James S.
Reports to the SEC for 2 companies · DURHAM, NC
Transactions
34
Companies
2
Filings
11
CIK
0001744887
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-09-09 | FTREFortrea Holdings Inc.S Sale | −$17.2K |
| 2025-09-08 | FTREFortrea Holdings Inc.M Exercise/Conversion | — |
| 2025-09-08 | FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion | — |
| 2025-06-03 | FTREFortrea Holdings Inc.S Sale | −$9,136.47 |
| 2025-06-02 | FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion | — |
| 2025-06-02 | FTREFortrea Holdings Inc.M Exercise/Conversion | — |
| 2025-03-14 | FTREFortrea Holdings Inc.S Sale | −$9,767.9 |
| 2025-03-13 | FTREFortrea Holdings Inc.M Exercise/Conversion | — |
| 2025-03-13 | FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion | — |
| 2025-03-07 | FTREFortrea Holdings Inc. · Restricted Stock UnitA Award | — |
| 2025-03-06 | FTREFortrea Holdings Inc. · Restricted Stock UnitA Award | — |
| 2024-06-12 | FTREFortrea Holdings Inc.P Purchase | +$50.6K |
| 2024-06-03 | FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion | — |
| 2024-06-03 | FTREFortrea Holdings Inc.F Tax Payment | −$55.4K |
| 2024-06-03 | FTREFortrea Holdings Inc.M Exercise/Conversion | — |
| 2024-03-13 | FTREFortrea Holdings Inc. · Restricted Stock UnitA Award | — |
| 2023-06-30 | FTREFortrea Holdings Inc. · Restricted Stock UnitA Award | — |
| 2023-06-30 | FTREFortrea Holdings Inc. · Restricted Stock UnitA Award | — |
| 2023-06-20 | FTREFortrea Holdings Inc.J Other | — |
| 2023-01-05 | G1 Therapeutics, Inc.S Sale | −$3,942.067 |
| 2023-01-04 | G1 Therapeutics, Inc.S Sale | −$9,138.408 |
| 2023-01-03 | G1 Therapeutics, Inc.Stock Options (Right to buy)A Award | — |
| 2023-01-03 | G1 Therapeutics, Inc.A Award | — |
| 2022-01-05 | G1 Therapeutics, Inc.S Sale | −$15.3K |
| 2022-01-03 | G1 Therapeutics, Inc.A Award | — |
| 2022-01-03 | G1 Therapeutics, Inc.Stock Options (Right to buy)A Award | — |
| 2021-01-04 | G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award | — |
| 2021-01-04 | G1 Therapeutics, Inc.A Award | — |
| 2020-09-04 | G1 Therapeutics, Inc.P Purchase | +$15K |
| 2020-02-06 | G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award | — |
| 2019-01-02 | G1 Therapeutics, Inc.Stock Options (Right to Buy)A Award | — |
| 2018-12-26 | G1 Therapeutics, Inc.P Purchase | +$18.3K |
| 2018-12-10 | G1 Therapeutics, Inc.P Purchase | +$32.5K |
| 2018-06-25 | G1 Therapeutics, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4Hanson James S.0001965040-25-000118SEC(opens sec.gov)
- 4Hanson James S.0001127602-25-016770SEC(opens sec.gov)
- 4Hanson James S.0001127602-25-009700SEC(opens sec.gov)
- 4Hanson James S.0001127602-25-008890SEC(opens sec.gov)
- 4Hanson James S.0001127602-24-018484SEC(opens sec.gov)
- 4Hanson James S.0001127602-24-017412SEC(opens sec.gov)
- 4Hanson James S.0001127602-24-010275SEC(opens sec.gov)
- 4/AHanson James S.0001127602-23-021030SEC(opens sec.gov)
- 4Hanson James S.0001127602-23-020281SEC(opens sec.gov)
- 4Hanson James S.0001127602-23-019157SEC(opens sec.gov)
- 4Hanson James S.0001562180-23-000250SEC(opens sec.gov)
Companies
Address
8 MOORE DRIVE
DURHAM, NC, 27709